BLGO - BioLargo, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

BioLargo, Inc.

14921 Chestnut Street
Westminster, CA 92683
United States

SectorBasic Materials
Full Time Employees25

Key Executives

NameTitlePayExercisedYear Born
Mr. Dennis P. CalvertPres, CEO & Chairman319.93kN/A1963
Mr. Charles K. Dargan II, C.F.A.Chief Financial OfficerN/AN/A1955
Mr. Joseph L. ProvenzanoVP of Operations, Corp. Sec. & Director186.34kN/A1969
Mr. Kenneth Reay CodeChief Science Officer & Director301.2kN/A1947
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


BioLargo, Inc. operates as a science, technology, and environmental engineering company. Its platform technologies include Advanced Oxidation System (AOS), CupriDyne, and Isan. The company offers odor and volatile organic compound control products, AOS water treatment technologies, and technologies in the medical and dental fields, as well as professional engineering services. It provides commercial, household, and personal care products, including an animal-bedding additive that controls odor and moisture; and liquid odor control products under the Odor-No-More, Nature's Best Science, Deodorall, and NBS brand names. BioLargo, Inc. was founded in 1989 and is based in Westminster, California.

Corporate Governance

BioLargo, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.